Music Therapy + Brain Stimulation for Corticobasal Syndrome
Trial Summary
What is the purpose of this trial?
This study is designed to investigate how musical patterns (e.g., patterned sensory enhancement, PSE) and non-invasive brain stimulation (e.g., transcranial direct current stimulation, tDCS) are effective to improve functional upper extremity performances in patients with corticobasal syndrome (CBS). 20 individuals with CBS will be randomly assigned to either PSE group (n= 10) or PSE+tDCS (n=10) group. Both interventions are 30 minutes long, twice a week for three weeks (a total of 6 sessions). Participants' self-reported and measurable outcomes including upper extremity function, kinematic quantities, quality of life, mood, cognitive level, and brain activity (e.g. electroencephalography, EEG) will be assessed in the baseline, pre- and post- each session, and follow-up phase. This study seeks to assess the possibility that music-based intervention and non-invasive brain stimulation may improve outcomes in CBS patients for patients' non-invasive but cost-effective rehabilitation settings in the future.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study coordinators or your doctor.
What data supports the effectiveness of the treatment Music Therapy + Brain Stimulation for Corticobasal Syndrome?
Research shows that combining transcranial direct current stimulation (tDCS) with music therapy can improve motor performance in conditions like Parkinson's disease and stroke. Music therapy techniques, such as rhythmic auditory stimulation, have been found to enhance motor coordination and cognitive functions by activating brain areas involved in movement and memory.12345
Is the combination of music therapy and brain stimulation safe for humans?
Research on transcranial direct current stimulation (tDCS) combined with music therapy suggests it is generally safe for humans, as studies have shown it can improve cognitive functions and motor performance without significant adverse effects. However, more research is needed to fully understand its safety across different conditions.12678
How does the treatment of Music Therapy + Brain Stimulation for Corticobasal Syndrome differ from other treatments?
This treatment is unique because it combines music therapy with brain stimulation to improve motor function in patients with corticobasal syndrome. The use of music therapy, specifically techniques like patterned sensory enhancement and rhythmic auditory stimulation, helps synchronize movements with music, while transcranial direct current stimulation (tDCS) enhances brain activity, making it a novel approach compared to traditional therapies.13459
Research Team
Alexander Pantelyat, MD
Principal Investigator
Department of Neurology, Johns Hopkins School of Medicine
Eligibility Criteria
This trial is for right-handed individuals aged 18-89 with corticobasal syndrome (CBS). It's not suitable for those with a history of seizures, skin conditions like psoriasis or eczema, psychological/neurological disorders, pregnancy, inability to follow study procedures, adverse reactions to brain stimulation techniques, migraines, metallic implants including pacemakers or past significant head injuries.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either PSE or PSE+tDCS interventions, 30 minutes per session, twice a week for three weeks
Follow-up
Participants are monitored for changes in upper extremity performance and other outcomes
Treatment Details
Interventions
- Patterned Sensory Enhancement (PSE)
- Transcranial Direct Current Stimulation (tDCS)
Patterned Sensory Enhancement (PSE) is already approved in United States, European Union for the following indications:
- Rehabilitation for upper extremity motor function in patients with corticobasal syndrome (CBS) and stroke
- Rehabilitation for upper extremity motor function in patients with stroke and neurodegenerative disorders
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor